Page 201 - AACN Essentials of Critical-Care Nursing Pocket Handbook, Second Edition

188

Not cardioselective; hypotension; bronchospasm; negative inotropy negative inotropy corneal microdeposits; hypo/ coumadin; increased digoxin level Therapeutic range: 1-2.5 mg/L

Comments Cardioselective at low doses; hypotension; negative inotropy; very short half-life Cardioselective at low doses; hypotension; Half-life 50 days; pulmonary fibrosis; hyperthyroidism; bluish skin; hepatitis; photosensitivity; condu

Up to 0.5-1 mg IV, then 1-4 mg/h (or 10-100 mg PO q6h) Maintenance dose: 50 mcg/kg/min; rebolus and increase q5min by 50 mcg/kg/min to maximum of 400 then 25-100 mg PO q8-12h 100-400 mg PO qd

Dosage Loading dose: 500 mcg/over 1 minute Initial IV dose: 5 mg q5min up to 15 mg, 800-1600 mg PO qd for 1-3 weeks, then 600-800 mg PO qd for 4 weeks, then

Antiarrhythmic Agents (continued) Indications Slowing ventricular rate in atrial fibrillation, atrial flutter, and SVT; suppression of PVCs Slowing ventricular rate in atrial fibrillation, atrial flutter, SVT, and MAT Slowing ventricular rate in atri

Agents Class II (beta- blocking agents) Propranolol Esmolol Metoprolol Class III Amiodarone
7.4